vTv Therapeutics Fails Late-Stage Alzheimer"s Study; Is There A Chance For A Comeback?

vTv Therapeutics Fails Late-Stage Alzheimer"s Study; Is There A Chance For A Comeback?.....»»

Category: topSource: seekingalphaApr 16th, 2018

Stifel Sees Challenging Road Ahead For vTv Therapeutics After Failed Alzheimer"s Trial

vTv Therapeutics Inc (NASDAQ: VTVT) announced Monday after the close that results from Part A of its late-stage study of an investigational medication to treat Alzheimer's disease did not m Latest Ratings for VTVT D.....»»

Category: blogSource: benzingaApr 10th, 2018

Pill for postpartum depression by Cambridge"s Sage succeeds in late-stage trial

Sage Therapeutics, one of Cambridge's largest biotech firms, today reported that its pill to treat postpartum depression appears to have succeeded in a late-stage trial. In a study of 151 women suffering from the condition, those who were given ora.....»»

Category: topSource: bizjournalsJan 7th, 2019

J&J"s Esketamine Fails to Meet Endpoint in Phase III Study

J&J's (JNJ) late-stage candidate, esketamine nasal spray, fails to show sta.....»»

Category: dealsSource: nytSep 24th, 2018

Histogenics Slips Below $1 Threshold After Knee Cartilage Candidate Fails Late-Stage Study

Histogenics Corp (NASDAQ: HSGX) shares were losing more than half their market value Wednesday following the release of top-line data from the Phase 3 trial of Neocar read more.....»»

Category: blogSource: benzingaSep 5th, 2018

Biogen Begins Improved Dosing Regimen on Tysabri in Phase III

Biogen (BIIB) commences enrollment in late-stage study to evaluate an expanded interval dosing of its MS drug.....»»

Category: personnelSource: nytJan 4th, 2019

Why Cara Therapeutics Is One of Wednesday’s Big Winners

Cara Therapeutics shares jumped on Wednesday after the firm announced a key update in its late-stage chronic kidney disease trial......»»

Category: blogSource: 247wallstJan 2nd, 2019

Stocks stage late-day comeback; Dow logs more than 200-point gain

U.S. stocks erased sharp losses to end mostly positive Thursday in a turbulent trading session that saw the Dow slump as much as 611 points earlier in the day. The S&P 500 finished higher by 0.8% to around2,489, based on prelim.....»»

Category: topSource: marketwatchDec 27th, 2018

Pfizer/Merck KGaA End Bavencio Ovarian Cancer Phase III Study

Pfizer (PFE) and Merck KGaA terminate a late-stage study on Bavencio. This is th.....»»

Category: smallbizSource: nytDec 24th, 2018

Pfizer Xtandi Succeeds in Late-Stage Prostate Cancer Study


Category: topSource: redinewsDec 21st, 2018

Evofem Shares Up as Birth Control Gel Succeeds in Phase III

Evofem (EVFM) stock surges on positive results from a late-stage study on experimental birt.....»»

Category: dealsSource: nytDec 18th, 2018

Eli Lilly Scores Solid Results in Psoriatic Arthritis Study

Eli Lilly shares were slightly lower after the company announced positive results from its late-stage active psoriatic arthritis study......»»

Category: blogSource: 247wallstDec 17th, 2018

Conatus" Emricasan Misses Primary Endpoint in Mid-Stage Study

Conatus' (CNAT) emricasan fails to meet the primary endpoint in a phase IIb study on compensated NASH cirrhosis patient.....»»

Category: dealsSource: nytDec 6th, 2018

Stocks stage comeback, Nasdaq rises after wild ride

A late day turnaround battled back the bears......»»

Category: topSource: foxnewsDec 6th, 2018

Supernus Gets Crushed Despite Positive ADHD Study Results

Supernus Pharmaceuticals shares dipped on Thursday despite the firm posted positive results from two of its late-stage studies in children for the treatment of attention deficit hyperactivity........»»

Category: blogSource: 247wallstDec 6th, 2018

Bristol-Myers Loses Out in Late-Stage Lung Cancer Study

Bristol-Myers Squibb shares dipped on Tuesday after the company reported results from its late-stage lung cancer study......»»

Category: blogSource: 247wallstNov 27th, 2018

Marijuana Stocks: GW Phamaceuticals Stock Surges on Late-Stage Study Success

InvestorPlace - Stock Market News, Stock Advice & Tra.....»»

Category: topSource: investorplaceNov 26th, 2018

Additional Late-Stage Study Confirms Efficacy, Safety Of GW Pharma"s Epidiolex

GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) announced incremental positive news on its lead cannabinoid product candidate Epidiolex, sending the stock higher. read more.....»»

Category: blogSource: benzingaNov 26th, 2018

Madrigal preparing for late-stage testing of experimental NASH treatment

Madrigal Pharmaceuticals presented "statistically significant" results from midstage testing of its lead new drug candidate for NASH during Monday's annual meeting of the American Association for the Study of Liver Diseases in San Francisco. The Conshoh.....»»

Category: topSource: bizjournalsNov 12th, 2018

Amarin Trades Down After Release Of Late-Stage Vascepa Trial Results

Amarin Corporation plc (NASDAQ: AMRN) shares were falling Monday following the presentation of detailed primary results from the the late-stage REDUCE-IT study that evaluated Vascep read more.....»»

Category: blogSource: benzingaNov 12th, 2018

Sarepta, Lysogene Announce Exclusive License Agreement for LYS - SAF302, a Late- stage Gene Therapy for the Treatment of MPS IIIA; Grant of Option Rights to an Additional CNS Gene Therapy Candidate

Sarepta Therapeutics, Inc. read more.....»»

Category: blogSource: benzingaOct 26th, 2018